Cargando…
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway
Ponatinib, a third-generation tyrosine kinase inhibitor (TKI), is the only approved TKI that is effective against T315I mutations in patients with chronic myeloid leukemia (CML). Specific activation of Notch signaling in CML cells by ponatinib can be considered as the “on-target effect” on the tumor...
Autores principales: | Madonna, Rosalinda, Pieragostino, Damiana, Cufaro, Maria Concetta, Doria, Vanessa, Del Boccio, Piero, Deidda, Martino, Pierdomenico, Sante Donato, Dessalvi, Christian Cadeddu, De Caterina, Raffaele, Mercuro, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141219/ https://www.ncbi.nlm.nih.gov/pubmed/32197359 http://dx.doi.org/10.3390/jcm9030820 |
Ejemplares similares
-
Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model
por: Madonna, Rosalinda, et al.
Publicado: (2022) -
Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model
por: Madonna, Rosalinda, et al.
Publicado: (2021) -
Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes
por: Madonna, Rosalinda, et al.
Publicado: (2020) -
Co‐expression of glycosylated aquaporin‐1 and transcription factor NFAT5 contributes to aortic stiffness in diabetic and atherosclerosis‐prone mice
por: Madonna, Rosalinda, et al.
Publicado: (2020) -
Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases
por: Deidda, Martino, et al.
Publicado: (2018)